LCG
TMO icon

Lakeshore Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Lakeshore Capital Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Buy
1,404
+8
+0.6% +$3.84K 0.52% 49
2026
Q1 		$686K Buy
1,396
+14
+1% +$7.6K 0.56% 51
2025
Q4 		$801K Buy
1,382
+30
+2% +$17K 0.64% 47
2025
Q3 		$656K Buy
1,352
+22
+2% +$10.2K 0.53% 57
2025
Q2 		$539K Buy
1,330
+398
+43% +$166K 0.48% 62
2025
Q1 		$464K Buy
932
+37
+4% +$20K 0.45% 64
2024
Q4 		$466K Buy
+895
New +$492K 0.7% 47

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Lakeshore Capital Group's TMO Position: Q2 2026 in Review

Lakeshore Capital Group increased its Thermo Fisher Scientific (TMO) stake by 0.57% in Q2 2026, buying an estimated $3.84K and bringing the position to 1,404 shares worth $704K. The position accounts for 0.52% of the portfolio, ranked #49.

Lakeshore Capital Group first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $801K in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Lakeshore Capital Group held 1,404 shares of Thermo Fisher Scientific worth $704K as of Q2 2026.
  • Lakeshore Capital Group bought 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.52% of Lakeshore Capital Group's portfolio in Q2 2026, its #49 holding.
  • Lakeshore Capital Group first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Lakeshore Capital Group's Thermo Fisher Scientific position peaked at $801K in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lakeshore Capital Group's 13F filing for Q2 2026, filed 31 Jul 2026.